Your institution may have access to this item. Find your institution then sign in to continue.
Title
ANEMIA DRUG MAY IMPAIR TUMOR CONTROL DURING RADIATION.
Abstract
Reports on a European study which suggests that giving some patients erythropoietin during radiotherapy may actually impair tumor control rather than increase the effectiveness of radiation. Existing practice of administering erythropoietin in the U.S.; Lack of benefits shown by the raising of hemoglobin concentrations.